What is Evolent Health Inc's share price today?
Evolent Health Inc (EVH) share price today is $4.32 as of September 5, 2026 at 1:30 AM IST. The stock touched a day high of $4.34 and a day low of $4.15.What exchange does Evolent Health Inc stock trade on, and under what ticker symbol?
Evolent Health Inc stock trades on NYSE under the ticker symbol EVH.What is Evolent Health Inc's market capitalization?
Evolent Health Inc's market capitalization is $478.24M as of September 5, 2026 at 1:30 AM IST.What is Evolent Health Inc's price-to-earnings (P/E) ratio?
Evolent Health Inc's price-to-earnings (P/E) ratio is N/A as of September 4, 2026.What is Evolent Health Inc's price-to-book (P/B) ratio?
Evolent Health Inc's price-to-book (P/B) ratio is 1.26 as of September 4, 2026.Can Indian investors buy Evolent Health Inc shares?
Yes, You can buy Evolent Health Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Evolent Health Inc shares from India?
Indian investors can buy Evolent Health Inc shares in three steps: 1. Search Evolent Health Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Evolent Health Inc shares for Indian investors?
Since Evolent Health Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Evolent Health Inc shares via Tickertape?
Indian investors can start investing in Evolent Health Inc (EVH) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 2.3121 shares at the current price of $4.32.
$
₹
$4.321.52% (+0.06)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
1D
1W
1M
1Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
—
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
1.26
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$-4.44
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
1.92
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
-24.08%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Analyst Ratings & ForecastAnalyst Ratings & Forecast
Analyst Ratings & Forecast
Analyst Ratings & Forecast
Based on 14 analysts' reports
Buy13 analysts
Hold1 analyst
Sell0 analyst
Analysts expect a +33.55% price upside over the next year
Current Price$4.32
Target Price$5.76
Company Profile
Peers
Peers
—
—
P/E Ratio
45.86
45.86
—
—
1Y Return
1.86%
1.86%
Buy Reco %
59.37
59.37
—
—
P/E Ratio
36.74
36.74
—
—
1Y Return
32.66%
32.66%
Buy Reco %
100.00
100.00
DOCS
—
—
P/E Ratio
31.33
31.33
—
—
1Y Return
61.54%
61.54%
Buy Reco %
42.10
42.10
—
—
P/E Ratio
13.92
13.92
—
—
1Y Return
26.92%
26.92%
Buy Reco %
72.22
72.22
OMCL
—
—
P/E Ratio
41.32
41.32
—
—
1Y Return
3.77%
3.77%
Buy Reco %
50.00
50.00
Peers & Comparison
Peers & Comparison
HealthcareHealth Information Services
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Evolent Health Inc | - | 1.26 | 1.92 |
| Veeva Systems Inc Class A | 45.86 | 6.08 | 1.24 |
| Waystar Holding Corp. Common Stock | 36.74 | 1.23 | - |
Price Comparison
Price Comparison
1 Month
1 Year
5 Years
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
| Financial Year | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 639.65 | 647.14 | 621.40 | 646.54 | 483.64 | 444.32 | 479.53 | 468.71 | 496.24 | 652.52 |
| Gross Profit | 104.10 | 106.84 | 80.69 | 75.71 | 102.47 | 76.94 | 75.85 | 52.21 | 61.91 | 80.83 |
| Net Income | -17.28 | 1.59 | -23.13 | -22.80 | -64.61 | -19.89 | -20.86 | -429.13 | -26.63 | -28.36 |
| Net Profit Margin | -2.70% | 0.24% | -3.72% | -3.52% | -13.36% | -4.47% | -4.35% | -91.55% | -5.36% | -4.34% |